COVID-19 vaccines do not increase your risk for stroke, new research shows, but severe COVID infection does, and experts hope the finding will ease the concerns of those who are hesitant to get the shot. “We now know that patients who’ve had a vaccine are not at higher risk of stroke, thanks to a large… read on > read on >
All Health and Wellness:
Biggest Study Yet Finds No Link Between Statins, Muscle Aches
Cholesterol-lowering statins are proven lifesavers, but they’ve also gained a reputation for causing muscle aches and pains in a good number of patients. That reputation is undeserved, according to a new large-scale analysis of data from nearly two dozen clinical trials of statins. There’s a less than 10% chance that muscle symptoms reported by patients… read on > read on >
Is There a Best Time of Day to Take Your Blood Pressure Pill?
It doesn’t seem to matter what time of day or night you take your blood pressure medication, a new study finds. The results of a randomized trial of more than 21,000 patients with high blood pressure who were followed for over five years show that protection against heart attack, stroke and vascular death is not… read on > read on >
Let the Sun In: More Natural Light at Home Lightens Your Mood
It’s safe to say that when searching for somewhere to live most people prefer open, airy spaces over dark and dingy ones. Now, new research suggests why: Homes filled with lots of natural light makes for happier residents. “We sought to explore the relationship between natural light and emotional well-being in residential indoor spaces,” explained… read on > read on >
Thousands of U.S. Patients Got COVID Treatments Rejected as Useless by FDA
U.S. doctors administered more than 150,000 doses of useless monoclonal antibody treatments to COVID-19 patients early this year, spending loads of cash on therapies that had been deemed of no benefit, a new study has found. The U.S. Food and Drug Administration deauthorized the use of two COVID monoclonal antibody treatments in January, after it… read on > read on >
Leading U.S. Pediatricians’ Group Issues Guidelines to Prevent Patient Abuse
Recent years have seen several high-profile cases of doctors sexually abusing young patients. Now the American Academy of Pediatrics (AAP) is issuing new recommendations aimed at prevention. Medical visits are usually a safe place for children and teenagers, but when abuse does happen, it is an egregious violation. One reason, the AAP says, is because… read on > read on >
All-in-One ‘Polypill’ Gets Heart Patients Taking Their Meds
In a finding that proves convenience is key when it comes to sticking to a medication regimen, new research shows that combining three heart drugs into one “polypill” slashes the risk of dying from a second heart attack by 33%. “The results of the SECURE study show that for the first time that the polypill,… read on > read on >
AHA News: Shift Workers With High Blood Pressure May Face Higher Heart Disease, Diabetes Risk
MONDAY, Aug. 29, 2022 (American Heart Association News) — People with high blood pressure may be at higher risk for developing cardiovascular disease and diabetes if they work frequent night shifts, new research suggests. The higher risk was more pronounced among people who also slept too much or too little when they weren’t working, according… read on > read on >
Alzheimer’s: Who Is Caring for the Caregivers?
MONDAY, Aug. 29, 2022 Katherine Sanden drove over 1,400 miles, from California to Nebraska, to care for her beloved uncle after he was diagnosed with Alzheimer’s in November 2020, but seeing him after years apart was more devastating than she could have ever imagined. Like Sanden, many family caregivers are thrown into the deep end… read on > read on >
ADHD Drug Adderall in Short Supply
Labor shortages at Teva Pharmaceuticals have made Adderall, a widely used attention-deficit/hyperactivity disorder (ADHD) drug, hard to find in some drugstores. But the U.S. Food and Drug Administration noted that there’s no overall shortage of ADHD medications. Only Teva is reporting supply problems, FDA spokeswomen Cherie Duvall-Jones told NBC News. “Teva Pharmaceuticals, the maker for… read on > read on >